Market Overview

Citigroup Initiates Coverage Jazz Pharmaceuticals at Buy, Announces PT of $70.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for JAZZ

DateFirmActionFromTo
May 2016Mizuho SecuritiesUpgradesNeutralBuy
Apr 2016SunTrust Robinson HumphreyUpgradesNeutralBuy
Feb 2016Stifel NicolausMaintainsBuy

View More Analyst Ratings for JAZZ
View the Latest Analyst Ratings

Posted-In: Price Target Initiation Analyst Ratings

 

Related Articles (JAZZ)